The indeterminate adrenal mass

Langenbeck's Archives of Surgery

Volumn 397, Issue 2, 2012, Pages 147-154

  Harrison, Barney ^a  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

Cross sectional imaging; Lipid poor adrenal mass; Percutaneous biopsy; PET

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADRENAL CORTEX ADENOMA; ADRENAL CORTEX CARCINOMA; ADRENAL METASTASIS; ADRENAL TUMOR; ADRENALECTOMY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONSENSUS; CONTRAST ENHANCEMENT; EVIDENCE BASED PRACTICE; HUMAN; INDETERMINATE ADRENAL MASS; INFORMATION RETRIEVAL; MEDLINE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT CARE; PHEOCHROMOCYTOMA; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW;

ADRENAL CORTEX NEOPLASMS; ADRENAL GLANDS; ADRENALECTOMY; ADRENOCORTICAL ADENOMA; ADULT; BIOPSY, FINE-NEEDLE; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC IMAGING; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; MALE; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84858864394     PISSN: 14352443     EISSN: 14352451     Source Type: Journal    
DOI: 10.1007/s00423-011-0845-0     Document Type: Review

References (57)

1. Pena CS, Boland GW, Hahn PF, Lee MJ, Mueller PR (2000) Characterization of indeterminate (lipid-poor) adrenal masses: use of washout characteristics at contrast-enhanced CT. Radiology 217(3):798-802
2. No authors listed (2002) NIH state-of-the-science statement on management of the clinically inapparent adrenal mass ("incidentaloma"). NIH Consens State Sci Statements 19(2):1-25
3. Zeiger MA, Thompson GB, Duh QY, Hamrahian AH, Angelos P, Elaraj D, Fishman E, Kharlip J (2009) The American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons medical guidelines for the management of adrenal incidentalomas. Endocr Pract 15(Suppl 1):1-20
4. Schteingart DE, Doherty GM, Gauger PG, Giordano TJ, Hammer GD, Korobkin M, Worden FP (2005) Management of patients with adrenal cancer: recommendations of an international consensus conference. Endocr Relat Cancer 12(3):667-680. doi:10.1677/erc.1.01029 (Pubitemid 41483000)
5. Barzon L, Sonino N, Fallo F, Palu G, Boscaro M (2003) Prevalence and natural history of adrenal incidentalomas. Eur J Endocrinol 149(4):273-285 (Pubitemid 37304697)
6. Young WF Jr (2007) Clinical practice. The incidentally discovered adrenal mass. N Engl J Med 356(6):601-610. doi:10.1056/NEJMcp065470
7. Hammarstedt L, Muth A, Wangberg B, Bjorneld L, Sigurjonsdottir HA, Gotherstrom G, Almqvist E, Widell H, Carlsson S, Ander S, Hellstrom M (2010) Adrenal lesion frequency: a prospective, cross-sectional CT study in a defined region, including systematic re-evaluation. Acta Radiol 51(10):1149-1156. doi:10.3109/02841851.2010.516016
8. Song JH, Chaudhry FS, Mayo-Smith WW (2008) The incidental adrenal mass on CT: prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known malignancy. AJR Am J Roentgenol 190(5):1163-1168. doi:10.2214/AJR.07.2799 (Pubitemid 351684914)
9. Song JH, Chaudhry FS, Mayo-Smith WW (2007) The incidental indeterminate adrenal mass on CT (> 10 H) in patients without cancer: is further imaging necessary? Follow-up of 321 consecutive indeterminate adrenal masses. AJR Am J Roentgenol 189(5):1119-1123. doi:10.2214/AJR.07.2167 (Pubitemid 350033002)
10. Welsh SJ, Khan S (2009) Radiological localizing techniques in adrenal tumors. Minerva Endocrinol 34(2):161-169
11. Lee JE, Evans DB, Hickey RC, Sherman SI, Gagel RF, Abbruzzese MC, Abbruzzese JL (1998) Unknown primary cancer presenting as an adrenal mass: frequency and implications for diagnostic evaluation of adrenal incidentalomas. Surgery 124 (6):1115-1122 (Pubitemid 28555203)
12. Kebebew E, Reiff E, Duh QY, Clark OH, McMillan A (2006) Extent of disease at presentation and outcome for adrenocortical carcinoma: have we made progress? World J Surg 30(5):872-878. doi:10.1007/s00268-005-0329-x (Pubitemid 43724119)
13. Allolio B, Fassnacht M (2006) Clinical review: adrenocortical carcinoma: clinical update. J Clin Endocrinol Metab 91(6):2027-2037. doi:10.1210/jc.2005- 2639 (Pubitemid 43854976)
14. Libe R, Fratticci A, Bertherat J (2007) Adrenocortical cancer: pathophysiology and clinical management. Endocr Relat Cancer 14(1):13-28. doi:10.1677/erc.1.01130 (Pubitemid 47521719)
15. Boscaro M, Fallo F, Barzon L, Daniele O, Sonino N (1995) Adrenocortical carcinoma: epidemiology and natural history. Minerva Endocrinol 20(1):89-94
16. Favia G, Lumachi F, Carraro P, D'Amico DF (1995) Adrenocortical carcinoma. Our experience. Minerva Endocrinol 20(1):95-99
17. Icard P, Goudet P, Charpenay C, Andreassian B, Carnaille B, Chapuis Y, Cougard P, Henry JF, Proye C (2001) Adrenocortical carcinomas: surgical trends and results of a 253-patient series from the French Association of Endocrine Surgeons study group. World J Surg 25(7):891-897 (Pubitemid 32666390)
18. Ng L, Libertino JM (2003) Adrenocortical carcinoma: diagnosis, evaluation and treatment. J Urol 169(1):5-11. doi:10.1097/01. ju.0000030148.59051.35
19. Abiven G, Coste J, Groussin L, Anract P, Tissier F, Legmann P, Dousset B, Bertagna X, Bertherat J (2006) Clinical and biological features in the prognosis of adrenocortical cancer: poor outcome of cortisol-secreting tumors in a series of 202 consecutive patients. J Clin Endocrinol Metab 91(7):2650-2655. doi:10.1210/jc.2005-2730 (Pubitemid 44024632)
20. Young WF Jr (2000) Management approaches to adrenal incidentalomas. A view from Rochester, Minnesota. Endocrinol Metab Clin North Am 29(1):159-185
21. Kasperlik-Zaluska AA, Otto M, Cichocki A, Roslonowska E, Slowinska-Srzednicka J, Jeske W, Papierska L, Zgliczynski W (2008) Incidentally discovered adrenal tumors: a lesson from observation of 1,444 patients. Horm Metab Res 40(5):338-341. doi:10.1055/s-2008-1073167 (Pubitemid 351859445)
22. O'Neill CJ, Spence A, Logan B, Suliburk JW, Soon PS, Learoyd DL, Sidhu SB, Sywak MS (2010) Adrenal incidentalomas: risk of adrenocortical carcinoma and clinical outcomes. J Surg Oncol 102 (5):450-453. doi:10.1002/jso.21553
23. Cawood TJ, Hunt PJ, O'Shea D, Cole D, Soule S (2009) Recommended evaluation of adrenal incidentalomas is costly, has high false-positive rates and confers a risk of fatal cancer that is similar to the risk of the adrenal lesion becoming malignant; time for a rethink? Eur J Endocrinol 161(4):513-527. doi:10.1530/EJE-09-0234
24. Sturgeon C, Shen WT, Clark OH, Duh QY, Kebebew E (2006) Risk assessment in 457 adrenal cortical carcinomas: how much does tumor size predict the likelihood of malignancy? J Am Coll Surg 202(3):423-430. doi:10.1016/j. jamcollsurg.2005.11.005 (Pubitemid 43356216)
25. Eldeiry LS, Garber JR (2008) Adrenal incidentalomas, 2003 to 2005: experience after publication of the National Institutes of Health consensus statement. Endocr Pract 14(3):279-284
26. Giordano R, Marinazzo E, Berardelli R, Picu A, Maccario M, Ghigo E, Arvat E (2010) Long-term morphological, hormonal, and clinical follow-up in a single unit on 118 patients with adrenal incidentalomas. Eur J Endocrinol 162(4):779-785. doi:10.1530/EJE-09-0957
27. Vassilatou E, Vryonidou A, Michalopoulou S, Manolis J, Caratzas J, Phenekos C, Tzavara I (2009) Hormonal activity of adrenal incidentalomas: results from a long-term follow-up study. Clin Endocrinol (Oxf) 70(5):674-679. doi:10.1111/j.1365-2265.2008.03492.x
28. Bernini GP, Moretti A, Oriandini C, Bardini M, Taurino C, Salvetti A (2005) Long-term morphological and hormonal follow-up in a single unit on 115 patients with adrenal incidentalomas. Br J Cancer 92(6):1104-1109. doi:10.1038/sj.bjc.6602459 (Pubitemid 40546676)
29. Yener S, Ertilav S, Secil M, Demir T, Akinci B, Kebapcilar L, Comlekci A, Bayraktar F, Yesil S (2010) Prospective evaluation of tumor size and hormonal status in adrenal incidentalomas. J Endocrinol Invest 33(1):32-36. doi:10.3275/6377
30. Yip L, Tublin ME, Falcone JA, Nordman CR, Stang MT, Ogilvie JB, Carty SE, Yim JH (2010) The adrenal mass: correlation of histopathology with imaging. Ann Surg Oncol 17(3):846-852. doi:10.1245/s10434-009-0829-2
31. Slattery JM, Blake MA, Kalra MK, Misdraji J, Sweeney AT, Copeland PM, Mueller PR, Boland GW (2006) Adrenocortical carcinoma: contrast washout characteristics on CT. AJR Am J Roentgenol 187(1):W21-W24. doi:10.2214/AJR.04. 1751
32. Johnson PT, Horton KM, Fishman EK (2009) Adrenal mass imaging with multidetector CT: pathologic conditions, pearls, and pitfalls. Radiographics 29(5):1333-1351. doi:10.1148/rg.295095027
33. Kamiyama T, Fukukura Y, Yoneyama T, Takumi K, Nakajo M (2009) Distinguishing adrenal adenomas from nonadenomas: combined use of diagnostic parameters of unenhanced and short 5-minute dynamic enhanced CT protocol. Radiology 250(2):474-481. doi:10.1148/radiol.2502080302
34. Sangwaiya MJ, Boland GW, Cronin CG, Blake MA, Halpern EF, Hahn PF (2010) Incidental adrenal lesions: accuracy of characterization with contrast-enhanced washout multidetector CT-10-minute delayed imaging protocol revisited in a large patient cohort. Radiology 256(2):504-510. doi:10.1148/radiol.10091386
35. Gupta RT, Ho LM, Marin D, Boll DT, Barnhart HX, Nelson RC (2010) Dual-energy CT for characterization of adrenal nodules: initial experience. AJR Am J Roentgenol 194(6):1479-1483. doi:10.2214/AJR.09.3476
36. Inan N, Arslan A, Akansel G, Anik Y, Balci NC, Demirci A (2008) Dynamic contrast enhanced MRI in the differential diagnosis of adrenal adenomas and malignant adrenal masses. Eur J Radiol 65(1):154-162. doi:10.1016/j.ejrad.2007. 03.012
37. Marin D, Soher BJ, Dale BM, Boll DT, Youngblood RS, Merkle EM (2010) Characterization of adrenal lesions: comparison of 2D and 3D dual gradient-echo MR imaging at 3 T-preliminary results. Radiology 254(1):179-187. doi:10.1148/radiol.09090486
38. Miller FH, Wang Y, McCarthy RJ, Yaghmai V, Merrick L, Larson A, Berggruen S, Casalino DD, Nikolaidis P (2010) Utility of diffusion-weighted MRI in characterization of adrenal lesions. AJR Am J Roentgenol 194(2):W179-W185. doi:10.2214/AJR.09.2891
39. Halefoglu AM, Yasar A, Bas N, Ozel A, Erturk SM, Basak M (2009) Comparison of computed tomography histogram analysis and chemical-shift magnetic resonance imaging for adrenal mass characterization. Acta Radiol 50(9):1071-1079. doi:10.3109/02841850903207170
40. Tessonnier L, Sebag F, Palazzo FF, Colavolpe C, De Micco C, Mancini J, Conte-Devolx B, Henry JF, Mundler O, Taieb D (2008) Does 18F-FDG PET/CT add diagnostic accuracy in incidentally identified non-secreting adrenal tumours? Eur J Nucl Med Mol Imaging 35(11):2018-2025. doi:10.1007/s00259-008-0849-3
41. Groussin L, Bonardel G, Silvera S, Tissier F, Coste J, Abiven G, Libe R, Bienvenu M, Alberini JL, Salenave S, Bouchard P, Bertherat J, Dousset B, Legmann P, Richard B, Foehrenbach H, Bertagna X, Tenenbaum F (2009) 18F-Fluorodeoxyglucose positron emission tomography for the diagnosis of adrenocortical tumors: a prospective study in 77 operated patients. J Clin Endocrinol Metab 94(5):1713-1722. doi:10.1210/jc.2008-2302
42. Nunes ML, Rault A, Teynie J, Valli N, Guyot M, Gaye D, Belleannee G, Tabarin A (2010) 18F-FDG PET for the identification of adrenocortical carcinomas among indeterminate adrenal tumors at computed tomography scanning. World J Surg 34(7):1506-1510. doi:10.1007/s00268-010-0576-3
43. Ansquer C, Scigliano S, Mirallie E, Taieb D, Brunaud L, Sebag F, Leux C, Drui D, Dupas B, Renaudin K, Kraeber-Bodere F (2010) 18F-FDG PET/CT in the characterization and surgical decision concerning adrenal masses: a prospective multicentre evaluation. Eur J Nucl Med Mol Imaging 37(9):1669-1678. doi:10.1007/s00259-010-1471-8
44. Ren R, Guo M, Sneige N, Moran CA, Gong Y (2006) Fine-needle aspiration of adrenal cortical carcinoma: cytologic spectrum and diagnostic challenges. Am J Clin Pathol 126(3):389-398. doi:10.1309/AQFEB5WEMU41N9K1 (Pubitemid 44338791)
45. Welch TJ, Sheedy PF 2nd, Stephens DH, Johnson CM, Swensen SJ (1994) Percutaneous adrenal biopsy: review of a 10-year experience. Radiology 193(2):341-344 (Pubitemid 24338311)
46. Kloos RT, Gross MD, Francis IR, Korobkin M, Shapiro B (1995) Incidentally discovered adrenal masses. Endocr Rev 16(4):460-484
47. Saeger W, Fassnacht M, Chita R, Prager G, Nies C, Lorenz K, Barlehner E, Simon D, Niederle B, Beuschlein F, Allolio B, Reincke M (2003) High diagnostic accuracy of adrenal core biopsy: results of the German and Austrian adrenal network multicenter trial in 220 consecutive patients. Hum Pathol 34 (2):180-186. doi:10.1053/hupa.2003.24 (Pubitemid 36258810)
48. Voravud N, Shin DM, Dekmezian RH, Dimery I, Lee JS, Hong WK (1992) Implantation metastasis of carcinoma after percutaneous fine-needle aspiration biopsy. Chest 102(1):313-315
49. Habscheid W, Pfeiffer M, Demmrich J, Muller HA (1990) Puncture track metastasis after ultrasound-guided fine-needle puncture biopsy. A rare complication? Dtsch Med Wochenschr 115(6):212-215. doi:10.1055/s-2008-1064995 (Pubitemid 20039292)
50. Lundstedt C, Stridbeck H, Andersson R, Tranberg KG, Andren-Sandberg A (1991) Tumor seeding occurring after fine-needle biopsy of abdominal malignancies. Acta Radiol 32(6):518-520
51. Smith EH (1991) Complications of percutaneous abdominal fine-needle biopsy. Rev Radiol 178(1):253-258
52. Lumachi F, Borsato S, Brandes AA, Boccagni P, Tregnaghi A, Angelini F, Favia G (2001) Fine-needle aspiration cytology of adrenal masses in noncancer patients: clinicoradiologic and histologic correlations in functioning and nonfunctioning tumors. Cancer 93(5):323-329. doi:10.1002/cncr.9047 (Pubitemid 32995216)
53. Stelow EB, Debol SM, Stanley MW, Mallery S, Lai R, Bardales RH (2005) Sampling of the adrenal glands by endoscopic ultrasound-guided fine-needle aspiration. Diagn Cytopathol 33 (1):26-30. doi:10.1002/dc.20273 (Pubitemid 40934417)
54. Eloubeidi MA, Black KR, Tamhane A, Eltoum IA, Bryant A, Cerfolio RJ (2010) A large single-center experience of EUS-guided FNA of the left and right adrenal glands: diagnostic utility and impact on patient management. Gastrointest Endosc 71 (4):745-753. doi:10.1016/j.gie.2009.10.022
55. Lumachi F, Borsato S, Tregnaghi A, Marino F, Fassina A, Zucchetta P, Marzola MC, Cecchin D, Bui F, Iacobone M, Favia G (2007) High risk of malignancy in patients with incidentally discovered adrenal masses: accuracy of adrenal imaging and image-guided fine-needle aspiration cytology. Tumori 93(3):269-274 (Pubitemid 47080013)
56. Quayle FJ, Spitler JA, Pierce RA, Lairmore TC, Moley JF, Brunt LM (2007) Needle biopsy of incidentally discovered adrenal masses is rarely informative and potentially hazardous. Surgery 142(4):497-502. doi:10.1016/j.surg.2007.07. 013, discussion 502-494
57. Mazzaglia PJ, Monchik JM (2009) Limited value of adrenal biopsy in the evaluation of adrenal neoplasm: a decade of experience. Arch Surg 144(5):465-470. doi:10.1001/archsurg.2009.59